nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of spleen lymphocytes by plasmid DNA
|
Rykova, Elena Yu |
|
1999 |
17 |
9-10 |
p. 1193-1200 8 p. |
artikel |
2 |
A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge
|
Tao, T |
|
1999 |
17 |
9-10 |
p. 1100-1108 9 p. |
artikel |
3 |
A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D 1 Presented in part: ASBMB/ASIP/AAI Joint Meeting, New Orleans, June 1996 (Abstract # 470) and Ph.D. thesis, Wright State University, August 1996. 1
|
Cruz, P.E. |
|
1999 |
17 |
9-10 |
p. 1091-1099 9 p. |
artikel |
4 |
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice
|
Babai, Ilan |
|
1999 |
17 |
9-10 |
p. 1239-1250 12 p. |
artikel |
5 |
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice
|
Babai, Ilan |
|
1999 |
17 |
9-10 |
p. 1223-1238 16 p. |
artikel |
6 |
Biodegradable microspheres containing influenza A vaccine: immune response in mice
|
Hilbert, Anne K |
|
1999 |
17 |
9-10 |
p. 1065-1073 9 p. |
artikel |
7 |
Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice
|
Guy, B |
|
1999 |
17 |
9-10 |
p. 1130-1135 6 p. |
artikel |
8 |
Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin
|
Hayward, Christopher M.M |
|
1999 |
17 |
9-10 |
p. 1272-1281 10 p. |
artikel |
9 |
Correspondence
|
|
|
1999 |
17 |
9-10 |
p. 1016- 1 p. |
artikel |
10 |
Correspondence
|
|
|
1999 |
17 |
9-10 |
p. 1015- 1 p. |
artikel |
11 |
Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge
|
Dean, H.J |
|
1999 |
17 |
9-10 |
p. 1117-1124 8 p. |
artikel |
12 |
Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination
|
Krüger, Sabine |
|
1999 |
17 |
9-10 |
p. 1145-1150 6 p. |
artikel |
13 |
Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system
|
Maes, D |
|
1999 |
17 |
9-10 |
p. 1024-1034 11 p. |
artikel |
14 |
Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization
|
Cho, Jae Ho |
|
1999 |
17 |
9-10 |
p. 1136-1144 9 p. |
artikel |
15 |
Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid
|
Chengalvala, Murty V |
|
1999 |
17 |
9-10 |
p. 1035-1041 7 p. |
artikel |
16 |
Evaluation of a new recombinant DNA hepatitis B vaccine (Shanvac-B)
|
Abraham, Philip |
|
1999 |
17 |
9-10 |
p. 1125-1129 5 p. |
artikel |
17 |
Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis
|
De Luca, Paula M |
|
1999 |
17 |
9-10 |
p. 1179-1185 7 p. |
artikel |
18 |
Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors 1 In conducting the research described in this report, the investigators adhered to the Guide for Care and Use of Laboratory Animals, as promulgated by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council. The facilities are fully accredited by the American Association for Accreditation of Laboratory Animal Care. The views of the authors do not purport to reflect the positions of the Department of the Army or the Department of Defense. 1
|
Hodgson, Loreen A. |
|
1999 |
17 |
9-10 |
p. 1151-1160 10 p. |
artikel |
19 |
Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide
|
Sturgess, Annie W |
|
1999 |
17 |
9-10 |
p. 1169-1178 10 p. |
artikel |
20 |
Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide
|
Leibl, Heinz |
|
1999 |
17 |
9-10 |
p. 1017-1023 7 p. |
artikel |
21 |
Immunization of dogs and cats with a DNA vaccine against rabies virus
|
Osorio, J.E |
|
1999 |
17 |
9-10 |
p. 1109-1116 8 p. |
artikel |
22 |
Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man
|
Niedrig, M |
|
1999 |
17 |
9-10 |
p. 1206-1210 5 p. |
artikel |
23 |
MHC class I- and class II-restricted processing and presentation of microencapsulated antigens
|
Men, Ying |
|
1999 |
17 |
9-10 |
p. 1047-1056 10 p. |
artikel |
24 |
Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants
|
Gherardi, M.Magdalena |
|
1999 |
17 |
9-10 |
p. 1074-1083 10 p. |
artikel |
25 |
Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites
|
Franke, Eileen D |
|
1999 |
17 |
9-10 |
p. 1201-1205 5 p. |
artikel |
26 |
Prevention of infection of influenza virus in DQ6 mice, a human model, by a peptide vaccine prepared according to the cassette theory
|
Matsuki, Naoto |
|
1999 |
17 |
9-10 |
p. 1161-1168 8 p. |
artikel |
27 |
Production of a highly immunogenic subunit ISCOM vaccine against Bovine Viral Diarrhea Virus
|
Kamstrup, S. |
|
1999 |
17 |
9-10 |
p. 1057-1064 8 p. |
artikel |
28 |
Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus
|
Piirainen, Liisa |
|
1999 |
17 |
9-10 |
p. 1084-1090 7 p. |
artikel |
29 |
Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine
|
Stefano, Isabel |
|
1999 |
17 |
9-10 |
p. 1042-1046 5 p. |
artikel |
30 |
Secondary vaccination with vaccinia virus recombinants: role of residual virulence of recombinants and immunogenicity of extrinsic antigens
|
Kutinová, Luda |
|
1999 |
17 |
9-10 |
p. 1186-1192 7 p. |
artikel |
31 |
Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines
|
Costantino, Paolo |
|
1999 |
17 |
9-10 |
p. 1251-1263 13 p. |
artikel |
32 |
The business of science and the science of business in the quest for an AIDS vaccine 1 Presented in abbreviated content at the 1998 Meeting of the Institute of Human Virology, Baltimore, MD, August 24, 1998. 1
|
Hilleman, Maurice R |
|
1999 |
17 |
9-10 |
p. 1211-1222 12 p. |
artikel |
33 |
The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines
|
Wilson, A.D |
|
1999 |
17 |
9-10 |
p. 1282-1290 9 p. |
artikel |
34 |
Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D
|
Haagmans, Bart L |
|
1999 |
17 |
9-10 |
p. 1264-1271 8 p. |
artikel |